CD4 Recovery Issues in HIV Patients on ART in Africa
Author Information
Author(s): Nakanjako Damalie, Kiragga Agnes, Ibrahim Fowzia, Castelnuovo Barbara, Kamya Moses R, Easterbrook Philippa J
Primary Institution: Infectious Diseases Institute, Makerere University, Kampala, Uganda
Hypothesis
Patients with suboptimal CD4 reconstitution are at increased risk of clinical events.
Conclusion
The frequency of suboptimal CD4 reconstitution is high in sub-Saharan Africa, but rates of AIDS-related clinical events were not higher in those with suboptimal CD4 reconstitution.
Supporting Evidence
- 21% of patients had suboptimal CD4 reconstitution at 6 months.
- Majority of patients with suboptimal CD4 at 6 months maintained this status up to 2 years.
- No significant differences in clinical events were found between patients with and without suboptimal CD4 reconstitution.
Takeaway
Some people taking HIV medicine don't get enough immune cells back, even when the virus is under control. This can be a problem, but it doesn't always lead to more sickness.
Methodology
Data from a prospective cohort of 559 patients initiating ART was analyzed to determine the frequency and predictors of suboptimal CD4 reconstitution.
Potential Biases
Potential biases may arise from the observational nature of the study and the specific patient population at a single facility.
Limitations
The study was limited to patients with sustained HIV-RNA viral suppression, which may not represent all patients on ART.
Participant Demographics
Of 559 patients, 69% were female, with a median age of 38 years and a median CD4 count of 98 cells/μl at baseline.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website